EFNA1, a ligand of EphA2 receptor tyrosine kinase, is overexpressed in AFP‐producing HCC and can induce the expression of genes associated with tumor cell growth, angiogenesis, invasion, and metastasis, leading to poor prognosis in HCC patients with AFP [35]. Here, EPHA2 is linked to hepatocellular carcinoma.